Physician profile
William G Robinson
NPI 1992286876
$673.12
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.00 · 2022: $262 · 2023: $193 · 2024: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $76.48 | 2022-2023 | |
| Corium, LLC | $55.21 | 2023-2024 | Azstarys |
| Lilly USA, LLC | $55.17 | 2022 | |
| Cranial Technologies, INC | $51.06 | 2022-2024 | Doc Band |
| Intuity Medical INC | $46.99 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $44.49 | 2022 | |
| Pfizer INC. | $39.37 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $36.38 | 2021-2024 | Farxiga |
| Amgen INC. | $30.51 | 2022-2023 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $29.43 | 2022-2024 | Vaxneuvance, Vaxelis, Gardasil |
| Paratek Pharmaceuticals, INC. | $28.81 | 2021 | |
| Novo Nordisk INC | $24.33 | 2021-2022 | |
| Daiichi Sankyo INC. | $24.02 | 2023 | Injectafer |
| Sanofi Pasteur INC. | $23.86 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.33 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vbi Vaccine (Delaware) INC. | $18.93 | 2023 | Prehevbrio |
| Noven Therapeutics, LLC | $17.17 | 2024 | Xelstrym |
| Abbvie INC. | $14.71 | 2021 | |
| Amneal Pharmaceuticals LLC | $14.52 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.78 | 2021 | |
| Genentech USA, INC. | $5.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.